FIGURE

Figure 3

ID

ZDB-FIG-220302-179

Publication

Schouten et al., 2022 - Stapling of Peptides Potentiates the Antibiotic Treatment of Acinetobacter baumannii In Vivo

Other Figures

All Figure Page

Back to All Figure Page

Figure 3

Peptide L8S1 is active in combination with vancomycin or rifampicin against A. baumannii in vivo. Zebrafish larvae survival rates were tracked over time following A. baumannii infection and treatment with stapled peptides, vancomycin or combinations of stapled peptide and vancomycin via caudal vein injection (A). MIC values of L8S1, rifampicin or erythromycin, MIC values of L8S1 combined with either rifampicin or erythromycin and MIC values of rifampicin or erythromycin combined with L8S1 were determined via checkerboard assay. The FIC values were defined as either the ratio of L8S1 in combination with rifampicin or erythromycin over the MIC value of L8S1 alone (FIC_L8S1), or the ratio of the MIC value of rifampicin or erythromycin combined with L8S1 over the MIC value of rifampicin or erythromycin alone (FIC_antibiotic) (B). Survival rates of A. baumannii infected zebrafish larvae were additionally followed upon treatment with peptide L11S1, rifampicin or a combination of L11S1 and rifampicin (C). The data are presented as mean ± standard deviation from three independent experiments.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Antibiotics (Basel)